Boston Scientific Corporation (NYSE: BSX) today announced positive data from the HI-PEITHO global randomized clinical trial evaluating the use of the EKOS™ Endovascular System in patients with ...
MedPage Today on MSN
In the hot seat at ACC: PE clot-buster, Impella-protected PCI, utility of CAC=0
Results of lung impedance-guided therapy in HFpEF also anticipated this weekend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results